Related Experiment Videos
[Herpes zoster neuralgia--a persistent therapeutic problem].
Nordisk Medicin
|January 1, 1989
Summary
Most acute herpes zoster (AHZ) patients under 50 recover without specific treatment. Older patients or those on immunosuppressants face high postherpetic neuralgia (PHN) risk, with early intervention showing promise for prevention.
Area of Science:
- Infectious Diseases
- Neurology
- Pain Management
Context:
- Acute herpes zoster (AHZ) commonly affects older adults and immunocompromised individuals.
- Postherpetic neuralgia (PHN) is a significant complication of AHZ, leading to severe pain.
- Current treatment for established PHN is often ineffective.
Purpose:
- To review current understanding and treatment strategies for preventing and managing postherpetic neuralgia (PHN).
- To highlight the importance of early intervention in acute herpes zoster (AHZ) for PHN prevention.
- To discuss various therapeutic approaches for PHN.
Summary:
- Younger patients with AHZ typically experience spontaneous recovery with NSAID-analgesics.
- Older patients and those on immunosuppressants are at higher risk for PHN and may require intensive pain management.
- Promising PHN prevention strategies include antiviral drugs, sympathetic blocks, corticosteroids, psychotropic, and anticonvulsive drugs, with earlier treatment yielding better outcomes.
- Established PHN treatment options are limited, with the Pain Clinic of Helsinki University Hospital utilizing antidepressive, neuroleptic drugs, and transcutaneous neurostimulation.
Impact:
- Early diagnosis and treatment of AHZ can significantly reduce the incidence and severity of PHN.
- This review provides insights into optimizing PHN prevention and management strategies.
- Highlights the need for further research into effective PHN treatments.